Dr. Joseph Kozikowski to serve in U.S. Medical Director and Business Development roles for leading Korean pharmaceutical company.
NATICK, MA – February 14, 2013 – Clinivation, Inc. announced today that clinivation Founder and CEO Joseph Kozikowski, M.D. has been appointed U.S. Medical Director, Business Development for Shin Poong Pharmaceutical Co., Ltd. (Korea Stock Exchange (KRX): 019170), with headquarters in Seoul, Korea.
In this role, Dr. Kozikowski will lead and support certain U.S.-focused medical, product development, regulatory, and business development initiatives for a number of marketed and pipeline products.
Quotes & Commentary:
“It is an honor and my pleasure to serve in this important role, and I thank Chairman Yong-Taek Chang and the Shin Poong executive leadership for their global vision and support,” said clinivation Founder and CEO Joseph Kozikowski, M.D.
About Shin Poong Pharmaceutical Company:
With operations in Korea, China, the Philippines, Vietnam, and Sudan, Shin Poong Pharmaceutical Co., Ltd. (Korea Stock Exchange (KRX): 019170) has established manufacturing and commercial partnerships with the world’s leading pharmaceutical companies, including GlaxoSmithKline, Taisho, AstraZeneca, Sanofi-Aventis, Eli Lilly, Pfizer, Merck, and others.
Shin Poong develops, manufactures, and sells pharmaceutical products in South Korea and internationally. It offers cardiovascular, anti-cancer, psychoneurotic, antirheumatic, and antihistamine drugs, as well as antibiotics, antiulcerants, anti-diabetics, antifungal and antiviral agents, benign prostatic hyperplasia, and trichogens. The company also synthesizes NSAID, cardiovascular, anti-ulcer, respiratory, anti-diabetic, anti-biotic, propulsive, anti-cancer, anti-arthritis, anti-spasmodic, and anti-helminthic APIs. In addition, it offers chemotherapeutics; hormones; contraceptive agents; vitamins and minerals; nutrition and dermatological products; and eye, ear, and mouth preparations, as well as neuro-muscular system, hematopoietic system, metabolism, alimentary system, genito-urinary system, and allergy and immune system APIs.
